Portal de investigação
Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1
Dados básicos
- Código:
- Estudo Clínico Académico
- Protocolo:
- Estudo Clínico Académico
- EUDRACT:
- NCT:
- Centro:
- Dotação:
- Ano de início:
- 2022
- Ano de conclusão:
Objectivos do projeto
Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
Bertoluci, MC; (...); Carvalho, D.
Review. 10.1186/s13098-023-01121-x. 2023
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Review. 2023
A 4-variable model to predict cardio-kidney events and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study
Mendon?a, L.; (...); Ferreira, J.
Article. 10.1159/000533223. 2023
Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
Sousa, C; (...); Sampaio, R
Article. 10.1007/s12020-022-03288-1. 2023
Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes.
Article. 2023
Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes
Ferreira, J.; (...); Neves, J.
Article. 10.1002/ejhf.2660. 2022
Association of glycemic variability and time in range with lipid profile in type 1 diabetes
Article. 10.1007/s12020-023-03464-x. 2024
Association of metabolic syndrome components and NAFLD with quality of life: Insights from a cross-sectional study.
Article. 2024
Association of thyroid function, within the euthyroid range, with cardiovascular risk: The EPIPorto study
Neves, J.; (...); Azevedo, A.
Article. 10.3389/fendo.2022.1067801. 2022
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed
Editorial Material. 10.1016/j.cardfail.2023.12.002. 2024
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed.
Article. 2024
Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort
Leite, AR; (...); Leite-Moreira, A
Article. 10.1159/000530136. 2023
Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis
Angelico Goncalves, A; (...); Ferreira, J.
Article. 10.1016/j.ijcard.2023.05.032. 2023
Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis.
Article. 2023
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes
Review. 10.1111/dom.16077. 2024
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes.
Review. 2024
Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment
Neves, J., Buysschaert, M, Bergman, M
Article. 10.3389/fendo.2023.1214479. 2023
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction
Neves, J.; (...); Leite Moreira, A.
Article. 10.1089/thy.2022.0717. 2023
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
Neves, JS; (...); Leite Moreira, A
Article. 2023
Efficacy, Toxicity, and Prognostic Factors of Re- treatment With [177Lu]Lu-DOTA-TATE in Patients With Progressing Neuroendocrine Tumors: The Experience of a Single Center
Article. 10.7759/cureus.47506. 2023
FIB-4 Index should Guide the Referral of Patients with Metabolic Syndrome to Gastroenterology: The Perspective of a Portuguese Cohort
Borges-Canha, M; (...); Freitas, P
Article. 10.26497/ao230023. 2023
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
Neves, J.; (...); Md, JPF
Article. 10.1016/j.jacc.2023.05.048. 2023
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes.
Article. 2023
Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind
Ferreira, J., Neves, J.
Editorial Material. 10.1002/ejhf.2693. 2022
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials
Ferreira, J.; (...); Neves, J.
Article. 10.1111/dom.14997. 2023
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
Ferreira, J.; (...); Neves, J.
Review. 10.1210/clinem/dgad398. 2023
Impact of the COVID-19 Pandemic on Maternal Weight Variation and Newborn Anthropometry at Birth.
Article. 2024
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials
Neves, J., Packer, M, Ferreira, J.
Article. 10.1016/j.cardfail.2023.03.017. 2023
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
Ferreira, J., Neves, J.
Letter. 10.1002/ejhf.2694. 2022
Myocardial stretch-induced compliance is abrogated under ischemic conditions and restored by cGMP/PKG-related pathways
Leite Moreira, AM; (...); Louren?o, A.
Article. 10.3389/fphys.2023.1271698. 2023
Myocardial stretch-induced compliance is abrogated under ischemic conditions and restored by cGMP/PKG-related pathways.
Article. 2023
Physical exercise and glycemic management in patients with type 1 diabetes on insulin pump therapy-a cross-sectional study.
Article. 2023
Prediabetes remission after bariatric surgery: a 4-years follow-up study
Article. 10.1186/s12902-024-01537-0. 2024
Relation between weight gain during pregnancy and postpartum reclassification in gestational diabetes
Coelho, S; (...); Ameida, MD
Article. 10.1007/s12020-023-03441-4. 2023
Relation between weight gain during pregnancy and postpartum reclassification in gestational diabetes.
Article. 2023
Response to Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure"
Ferreira, JP, Neves, JS
Letter. 10.1210/clinem/dgad507. 2023
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
Neves, J.; (...); Ferreira, J.
Article. 10.1111/dom.14862. 2023
Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis
Article. 10.1210/clinem/dgae087. 2024
Sulfur Amino Acid Restriction Mitigates High-Fat Diet-Induced Molecular Alterations in Cardiac Remodeling Primarily via FGF21-Independent Mechanisms
Article. 10.3390/nu16244347. 2024
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes A Meta-Analysis of Randomized Placebo-Controlled Trials
Article. 10.2215/CJN.0000000584. 2024
The role of Graves' disease in the development of thyroid nodules and thyroid cancer
Soares, MN; (...); Carvalho, D
Article. 10.1530/ETJ-23-0055. 2023
Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes
Bezerra, MF; (...); Carvalho, D
Article. 10.1186/s13098-023-01219-2. 2023
Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes.
Article. 2023
Total thyroidectomy in a patient awaiting heart transplant with amiodarone-induced thyrotoxicosis: A case report
Amador, F; (...); Carvalho, D.
Article. 10.1002/ccr3.6892. 2023
